Of 212 patients with duodenal ulcer treated with four weeks of one gram daily cimetidine, 25 had ulcers which underwent no reduction in size despite treatment. The effects of tripotassium dicitrato bismuthate (TDB) tablet four times a day or cimetidine 1.6 g daily on the healing of these cimetidine resistant ulcers were compared in a randomised crossover trial. Ten of 12 patients on tripotassiu...

Eighty patients with duodenal ulcer were randomly allocated to treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Ulcers healed in 78% of patients treated with TDB and in 74% treated with cimetidine, supporting previous observations that the efficacy of these two agents is similar. Duodenal ulcer recurred in 43% of patients in the 12 months after treatment with TDB an...

This article revisits the properties of BaBiO3 examined extensively in last two decades because its electronic as a superconductor and semiconductor photocatalyst. Solid-state syntheses this bismuthate have often involved BaCO3 barium source, which may lead to formation BaBiO3/BaCO3 heterostructures that could an impact on and, more importantly, photocatalytic activity bismuthate. Accordingly, ...

A number of seemingly neurotic symptoms, similar to those reported in bismuth intoxication, occurred in a patient taking a proprietary dyspeptic preparation, tri-potassium dicitrate bismuthate (De-Nol), over 2 years. The symptoms remitted over 10-12 months after stopping the drug - a similar period to that described in bismuth intoxication and the patient has remained symptom-free for 7 years. ...